Key facts
- This page summarizes Todd Hornsby's Form 4/A - Amendment filing for Apyx Medical Corp (APYX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Jun 2023, 16:42.
Todd Hornsby - 26 Jun 2023 Form 4/A - Amendment Insider Report for Apyx Medical Corp (APYX)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- APYX
- Reported as of
- 26 Jun 2023
- Net transaction value
- -$86,850
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 29 Jun 2023, 16:42:04 UTC
- Original report date
- 28 Jun 2023
- Prior SEC filing
- 13 Jan 2023
- Next SEC filing
- 11 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- Todd Hornsby
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Todd Hornsby filed Form 4/A - Amendment for Apyx Medical Corp (APYX) on 29 Jun 2023.
Change
- Previous filing in this sequence was filed on 13 Jan 2023.
- Current net transaction value: -$86,850.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APYX
transaction
Common Stock
Options Exercise
- Transaction value
- $26,550
- Shares
- +15,000
- Change %
- Price
- $1.77
- Shares after
- 15,000
- Date
- 26 Jun 2023
- Ownership
- Direct
APYX
transaction
Common Stock
Sale
- Transaction value
- $113,400
- Shares
- -15,000
- Change %
- -100%
- Price
- $7.56
- Shares after
- 0
- Date
- 26 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APYX
transaction
Derivative
Stock Option (Option to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -15,000
- Change %
- -43%
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 26 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $1.77
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023
Footnote F2
This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Footnote F3
The original Form 4 is hereby amended to correct the amount of securities beneficially owned by the Reporting Person (as set forth in Column 5 of Table I) following the previously reported transactions